ISARNA THERAPEUTICS
DEAD

Serial Number

90579137

Owner

ISARNA Therapeutics GmbH

Attorney

Claudia W. Stangle

Filing Date

Mar 15, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ISARNA THERAPEUTICS Trademark

Serial Number: 90579137

ISARNA THERAPEUTICS is a trademark filed by ISARNA Therapeutics GmbH on March 15, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

ISARNA Therapeutics GmbH (2 trademarks)

Munich 80798 , DE

Entity Type: 99

Trademark Details

Filing Date

March 15, 2021

Registration Date

Not Registered

Published for Opposition

May 17, 2022

Goods & Services

Pharmaceutical and veterinary preparations for the treatment of tumors, pain, neurological diseases, liver disease, ophthalmologic diseases, pulmonary disease, renal diseases, and any other disease that is associated with the biologic action of Transforming Growth Factor beta (TGF-b) of the human body or of animals; sanitary preparations for medical purposes; liquids, solutions or active agents for use in the pharmaceutical and veterinary field, namely, for the treatment of tumors, pain, neurological diseases, liver disease, ophthalmologic diseases, pulmonary disease, renal diseases, and any other disease that is associated with the biologic action of Transforming Growth Factor beta (TGF-b) of the human body or of animals

Medical services in the pharmaceutical field, namely, the treatment of tumors, pain, neurological diseases and similar malfunctioning of the human body; veterinary services in the field of the treatment of tumors, pain, neurological diseases and similar malfunctioning of animals; hygienic and beauty care for human beings or animals, using liquids, solutions or active agents in the cosmetic field, namely, the plastic surgery and anaplastic field or anti-aging treatment

Scientific and technological services, namely, research and design relating thereto in the pharmaceutical and veterinary field, namely, for the treatment of tumors, pain, neurological diseases and similar malfunctioning of the human body or of animals; industrial analysis in the nature of testing pharmaceuticals to ensure compliance with industry standards; providing scientific research services in the fields of medicine, namely, research on tumor treatment, pain, neurological diseases and similar malfunctioning of the human body or of animals; design and development of computer hardware and software in the pharmaceutical and veterinary field, namely, for the treatment of tumors, pain, neurological diseases and similar malfunctioning of the human body or of animals

Filing History

ASSIGNED TO EXAMINER
May 5, 2026 DOCK
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 16, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 16, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 16, 2024 EXRA
SOU EXTENSION 5 GRANTED
Oct 16, 2024 EX5G
SOU EXTENSION 5 FILED
Oct 16, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Oct 16, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 17, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jun 17, 2024 EX4G
SOU EXTENSION 4 FILED
Jun 17, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 17, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 14, 2023 EXRA
SOU EXTENSION 3 GRANTED
Dec 12, 2023 EX3G
SOU EXTENSION 3 FILED
Dec 12, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 12, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 16, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jun 14, 2023 EX2G
SOU EXTENSION 2 FILED
Jun 14, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 14, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 10, 2022 EXRA
SOU EXTENSION 1 GRANTED
Dec 8, 2022 EX1G
SOU EXTENSION 1 FILED
Dec 8, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 8, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 12, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 17, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 17, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 27, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 13, 2022 PREV
ASSIGNED TO LIE
Apr 13, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 11, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 11, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 11, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 11, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 14, 2021 GNRN
NON-FINAL ACTION E-MAILED
Oct 14, 2021 GNRT
NON-FINAL ACTION WRITTEN
Oct 14, 2021 CNRT
ASSIGNED TO EXAMINER
Oct 14, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 14, 2021 NWOS
NEW APPLICATION ENTERED
Mar 18, 2021 NWAP